DermTech Inc
NASDAQ:DMTK
DermTech Inc
Total Liabilities
DermTech Inc
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
DermTech Inc
NASDAQ:DMTK
|
Total Liabilities
$63m
|
CAGR 3-Years
97%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Total Liabilities
$140.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Liabilities
$38.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
10%
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Liabilities
$88B
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Liabilities
$5.4B
|
CAGR 3-Years
20%
|
CAGR 5-Years
24%
|
CAGR 10-Years
19%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Liabilities
$7.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
22%
|
See Also
What is DermTech Inc's Total Liabilities?
Total Liabilities
63m
USD
Based on the financial report for Mar 31, 2024, DermTech Inc's Total Liabilities amounts to 63m USD.
What is DermTech Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
57%
Over the last year, the Total Liabilities growth was -10%. The average annual Total Liabilities growth rates for DermTech Inc have been 97% over the past three years , 57% over the past five years .